Showing 2,501 - 2,520 results of 63,920 for search '(( 5 ((wt decrease) OR (we decrease)) ) OR ( 50 ((nn decrease) OR (a decrease)) ))', query time: 1.16s Refine Results
  1. 2501

    Loss of C9orf72 decreases mTOR activation. by Janet Ugolino (3359054)

    Published 2016
    “…C9orf72-/- MEF cells show a decrease in p-S6K1 when compared with wild-type cells. …”
  2. 2502
  3. 2503

    Panel (a) compares SO<sub>2</sub> emissions prescribed over the historical period in the CMIP5 simulations (solid grey) with three inventory-based estimates of historical emissions... by Nathan P Gillett (557010)

    Published 2013
    “…In CanESM2 simulations, we find that under the RCP 2.6 scenario, which includes the fastest decrease in aerosol and aerosol precursor emissions, the contribution of aerosol reductions to warming between 2000 and 2040 is around 30%. …”
  4. 2504
  5. 2505
  6. 2506
  7. 2507
  8. 2508
  9. 2509

    Loss of Trib2 decreases disease latency of Notch-driven T-ALL. by Sarah J. Stein (3168600)

    Published 2016
    “…Mice with a body condition score of ≤2 and decreased mobility were euthanized (n = 8 Trib2<sup>+/+</sup> and n = 12 Trib2<sup>-/-</sup> recipients. …”
  10. 2510
  11. 2511
  12. 2512
  13. 2513

    DHA deficiency decreases NeuN positive cells after TBI. by Abhishek Desai (515392)

    Published 2014
    “…<p>DHA depleted mice showed decreased NeuN positive cells in the peri-contusional cortices relative to the DHA adequate mice as indicated by the representative micrographs (A) and quantitative analysis (B) of 25 brain sections from 5 mice. …”
  14. 2514

    Nitrile in the Hole: Discovery of a Small Auxiliary Pocket in Neuronal Nitric Oxide Synthase Leading to the Development of Potent and Selective 2‑Aminoquinoline Inhibitors by Maris A. Cinelli (1309419)

    Published 2017
    “…Neuronal nitric oxide synthase (nNOS) inhibition is a promising strategy to treat neurodegenerative disorders, but the development of nNOS inhibitors is often hindered by poor pharmacokinetics. We previously developed a class of membrane-permeable 2-aminoquinoline inhibitors and later rearranged the scaffold to decrease off-target binding. …”
  15. 2515
  16. 2516
  17. 2517
  18. 2518

    Results for four illustrative latent topics specified by a 50-topic CGC LDA model estimated from a corpus with 5,225 documents and a vocabulary of 28,971 words by DM Blei (19075)

    Published 2011
    “…CGC-based topic labels are a subset of the 50 × 500 topic annotation words that are unique to a topic and are words from the CGC vocabulary; these labels are ordered according to decreasing values. …”
  19. 2519
  20. 2520

    The estrogen receptor-α agonist PPT decreases cardiac myofilament activation. by Justyna Kulpa (313372)

    Published 2013
    “…Actomyosin MgATPase activity at submaximal calcium levels (<10 µM free calcium) was decreased with estrogen receptor-α activation. EC<sub>50</sub> values were increased, demonstrating a decrease in myofilament calcium sensitivity. …”